# 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis

> **NCT00450242** · PHASE2 · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 14 (actual)

## Conditions studied

- Vulvar Vestibulitis

## Interventions

- **DRUG:** 5% topical lidocaine ointment
- **DRUG:** Placebo cream

## Key facts

- **NCT ID:** NCT00450242
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** lack of funding
- **Last updated:** 2012-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00450242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00450242, "5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00450242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*